$MEDP News

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy

Medpace: Downgrade 'Hold' Revenue Growth Guidance Change And Slightly Lower Backlog Conversion Rate

MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues

UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700

Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633

5 revealing analyst questions from Medpace’s Q3 earnings call

Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675

TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673

Does Medpace Holdings (MEDP) Leave Any Room For Cash Flow Upside?

Medpace Holdings (MEDP) Beat Q3 Estimates, Is It Still 24% Overvalued?

Medpace Slumps On Solid Report — Where Are The 'Holes?'

Is Medpace Holdings (MEDP) Signaling Confidence With A $1 Billion Buyback?

Medpace Recovers From Post-Release Malaise; There Are 'No Holes To Poke' In Its Report

Medpace (MEDP) Q3 2026 Earnings Call Transcript

Medpace Q3 Earnings Call Highlights

Medpace Holdings, Inc. Q3 2026 Earnings Call Summary

Medpace Hldgs Q3 2026 Earnings Call Transcript

Medpace beats Q3 estimates but guides below on revenue

Medpace Slips Despite Solid Report; Where Are The 'Holes?'